[1. Nelson PE, Dignani MC, Anaissie EJ. Taxonomy, biology, and clinical aspects of Fusarium species. Clin Microbiol Rev. 1994;7(4):479-504.10.1128/CMR.7.4.479]Open DOISearch in Google Scholar
[2. Galimberti R, Torre AC, Baztán MC, Rodriguez-Chiappetta F. Emerging systemic fungal infections. Clin Dermatol. 2012;30(6):633-50.2306815110.1016/j.clindermatol.2012.01.011]Search in Google Scholar
[3. Nucci M, Anaissie E. Fusarium infections in immunocompromised pat ients. Cl in Microbiol Rev. 2007;20(4):695-704.10.1128/CMR.00014-07]Open DOISearch in Google Scholar
[4. Fridkin SK, Jarvis WR. Epidemiology of nosocomial fungal infections. Clin Microbiol Rev. 1996;9(4):499-511.10.1128/CMR.9.4.499]Open DOISearch in Google Scholar
[5. Dignani MC, Anaissie E. Human fusariosis. Clin Microbiol Infect. 2004;10 Suppl 1:67-75.1474880310.1111/j.1470-9465.2004.00845.x]Search in Google Scholar
[6. Nucci F, Nouér SA, Capone D, Anaissie E, Nucci M. Fusariosis. Semin Respir Crit Care Med. 2015; 36(5):706-14.10.1055/s-0035-1562897]Search in Google Scholar
[7. Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2011;52(4):e56-93.10.1093/cid/cir073]Open DOISearch in Google Scholar